Doseology Sciences Inc.
Doseology Sciences Inc. (MOOD.CN) Stock Overview
Explore Doseology Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8.6M
P/E Ratio
-27.84
EPS (TTM)
$-0.06
ROE
-0.34%
MOOD.CN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Doseology Sciences Inc. (MOOD.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 71.88, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.11.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.84 and a market capitalization of 8.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders. The company sells its products online through doseology.com. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Christopher Jackson
406-460 Doyle Avenue, Kelowna, BC
2021